Balance Sheet Tokyo Seimitsu Co., Ltd.

Equities

7729

JP3580200008

Semiconductor Equipment & Testing

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-03-13 am EDT			5-day change	1st Jan Change
14,415.00 ^JPY	-3.61%		-11.78%	+29.81%

Feb. 09	Jefferies Adjusts Tokyo Seimitsu's Price Target to 17,000 Yen from 14,000 Yen, Keeps at Buy	MT
Feb. 06	Tokyo Seimitsu Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI

bb.QTh3u4ehIHwg8am7v2Oba_i8E9G8zS3J3oF28uXLM2E.dV5F5MDpQTllmPz-9ijDJ8r1IoTr4Grwjesgmq-UfCAUVhz6wNQNMnDFxg

Published financial data: TOKYO SEIMITSU CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	97.1B	133B	147B	135B	151B
Total Revenues	97.1B	133B	147B	135B	151B
Cost of Goods Sold, Total	60.19B	79.77B	84.97B	79.92B	88.08B
Gross Profit	36.92B	53.5B	61.83B	54.76B	62.45B
Selling General & Admin Expenses, Total	14.16B	16.82B	18.77B	20.46B	22.38B
Provision for Bad Debts	112M	-17M	23M	-46M	19M
R&D Expenses	7.19B	8.15B	8.54B	9.04B	10.35B
Other Operating Expenses, Total	21.46B	24.95B	27.34B	29.45B	32.75B
Operating Income	15.45B	28.55B	34.5B	25.31B	29.7B
Interest Expense, Total	-72M	-50M	-40M	-105M	-202M
Interest And Investment Income	108M	391M	496M	342M	388M
Net Interest Expenses	36M	341M	456M	237M	186M
Currency Exchange Gains (Loss)	121M	255M	10M	530M	-247M
Other Non Operating Income (Expenses)	258M	242M	334M	434M	297M
EBT, Excl. Unusual Items	15.87B	29.39B	35.3B	26.51B	29.94B
Gain (Loss) On Sale Of Investments	133M	383M	96M	23M	139M
Gain (Loss) On Sale Of Assets	-	-	-	-60M	4.3B
Asset Writedown	-668M	-31M	-184M	-	-
Legal Settlements	-	-	-	-7M	-
Other Unusual Items	815M	4M	-1.91B	787M	-107M
EBT, Incl. Unusual Items	16.15B	29.74B	33.3B	27.25B	34.27B
Income Tax Expense	3.98B	8.25B	9.61B	7.79B	8.53B
Earnings From Continuing Operations	12.17B	21.5B	23.69B	19.46B	25.74B
Net Income to Company	12.17B	21.5B	23.69B	19.46B	25.74B
Minority Interest	6M	-57M	-62M	-84M	-106M
Net Income - (IS)	12.18B	21.44B	23.63B	19.38B	25.64B
Net Income to Common Incl Extra Items	12.18B	21.44B	23.63B	19.38B	25.64B
Net Income to Common Excl. Extra Items	12.18B	21.44B	23.63B	19.38B	25.64B
Per Share Items
Net EPS - Basic	293.83	525.33	581.31	480.47	633.74
Basic EPS - Continuing Operations	293.83	525.33	581.31	480.47	633.74
Basic Weighted Average Shares Outstanding	41.44M	40.81M	40.65M	40.33M	40.45M
Net EPS - Diluted	291.43	520.3	575.62	475.42	628.31
Diluted EPS - Continuing Operations	291.43	520.3	575.62	475.42	628.31
Diluted Weighted Average Shares Outstanding	41.78M	41.21M	41.05M	40.76M	40.8M
Normalized Basic EPS	239.48	448.64	541.15	408.73	459.93
Normalized Diluted EPS	237.51	444.34	535.83	404.42	455.98
Dividend Per Share	84	185	235	192	253
Payout Ratio	27.38	27.78	36.14	44.78	34.31
Supplemental Items
EBITDA	19B	32.16B	38.37B	30.04B	34.86B
EBITA	15.48B	28.58B	34.54B	25.36B	29.75B
EBIT	15.45B	28.55B	34.5B	25.31B	29.7B
Effective Tax Rate - (Ratio)	24.64	27.73	28.85	28.59	24.89
Normalized Net Income	9.92B	18.31B	22B	16.48B	18.61B
Non-Cash Pension Expense	-1.41B	-242M	-127M	-267M	-280M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	7.19B	8.15B	8.54B	9.04B	10.35B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	43.66B	49.03B	40.08B	36.78B	54.54B
Total Cash And Short Term Investments	43.66B	49.03B	40.08B	36.78B	54.54B
Accounts Receivable, Total	30.9B	38.33B	43.35B	42.77B	39.76B
Total Receivables	30.9B	38.33B	43.35B	42.77B	39.76B
Inventory	32.88B	40.28B	53.48B	67.22B	69.51B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	4.08B	6.14B	7.07B	7.06B	5.52B
Total Current Assets	112B	134B	144B	154B	169B
Net Property Plant And Equipment	36.64B	43.48B	48.95B	56B	53.98B
Long-term Investments	5.86B	5.51B	7.94B	8.08B	6.66B
Goodwill	220M	210M	279M	255M	224M
Other Intangibles, Total	3.77B	3.46B	3.67B	3.81B	3.5B
Loans Receivable Long-Term	231M	142M	142M	140M	138M
Deferred Tax Assets Long-Term	3.32B	3.6B	4.07B	3.41B	4.1B
Other Long-Term Assets, Total	1M	-	1M	1M	1M
Total Assets	162B	190B	209B	226B	238B
Liabilities
Accounts Payable, Total	23.06B	29.88B	22.36B	17.84B	16.66B
Accrued Expenses, Total	1.38B	1.72B	2.64B	2.24B	2.67B
Short-term Borrowings	1.3B	1.3B	1.3B	1.3B	1.3B
Current Portion of Long-Term Debt	2B	2B	4B	5B	5B
Current Portion of Leases	114M	114M	278M	228M	327M
Current Income Taxes Payable	3.94B	4.45B	6.32B	2.6B	5.83B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	7.5B	16.18B	14.04B	16.79B	15.14B
Total Current Liabilities	39.3B	55.64B	50.95B	46B	46.93B
Long-Term Debt	4B	2B	8B	18B	13B
Long-Term Leases	167M	79M	612M	642M	456M
Pension & Other Post Retirement Benefits	1.11B	1.17B	1.3B	1.22B	865M
Deferred Tax Liability Non Current	6M	6M	6M	-	-
Other Non Current Liabilities	205M	305M	2.14B	1.24B	471M
Total Liabilities	44.78B	59.2B	63B	67.1B	61.72B
Common Stock, Total	10.82B	11B	11.06B	11.45B	11.57B
Additional Paid In Capital	21.92B	22.12B	22.18B	22.59B	23.16B
Retained Earnings	83.87B	99.24B	114B	125B	142B
Treasury Stock	-3.12B	-5.59B	-7.1B	-7.98B	-8.43B
Comprehensive Income and Other	2.77B	3.65B	5.21B	6.88B	7.32B
Total Common Equity	116B	130B	145B	158B	175B
Minority Interest	516M	574M	668M	784M	1.06B
Total Equity	117B	131B	146B	158B	176B
Total Liabilities And Equity	162B	190B	209B	226B	238B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	41.07M	40.66M	40.24M	40.45M	40.48M
ECS Total Common Shares Outstanding	41.04M	40.65M	40.37M	40.4M	40.46M
Book Value / Share	2.83K	3.21K	3.6K	3.9K	4.33K
Tangible Book Value	112B	127B	141B	154B	171B
Tangible Book Value Per Share	2.74K	3.12K	3.5K	3.8K	4.24K
Total Debt	7.58B	5.49B	14.19B	25.17B	20.08B
Net Debt	-36.08B	-43.54B	-25.89B	-11.61B	-34.46B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-1.15B	-1.02B	-1.15B	-1.79B	-2.13B
Minority Interest, Total (Incl. Fin. Div)	516M	574M	668M	784M	1.06B
Inventories - Raw Materials, Total	8.2B	11.25B	18.16B	26.29B	26.6B
Inventories - Work In Process, Total	22.03B	26.22B	32.86B	38.68B	40.05B
Inventories - Finished Goods, Total	2.66B	2.81B	2.46B	2.25B	2.86B
Full Time Employees	2.29K	2.35K	2.47K	2.66K	2.77K
Accumulated Allowance for Doubtful Accounts (Supple)	50M	40M	57M	33M	46M
Order Backlog	56.92B	115B	102B	88B	83.1B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	16.15B	29.75B	33.3B	27.26B	34.28B
Depreciation & Amortization - CF	3.52B	3.57B	3.83B	4.67B	5.1B
Amortization of Goodwill and Intangible Assets - (CF)	28M	30M	42M	54M	49M
Depreciation & Amortization, Total	3.54B	3.6B	3.87B	4.73B	5.15B
(Gain) Loss From Sale Of Asset	668M	31M	184M	-	-4.3B
(Gain) Loss on Sale of Investments - (CF)	-133M	-25M	-25M	-23M	-179M
Other Operating Activities, Total	-1.18B	-7.58B	-7.45B	-10.71B	-5.81B
Change In Accounts Receivable	-987M	-6.58B	-4.39B	1.62B	3.03B
Change In Inventories	-3.49B	-7.15B	-12.89B	-13.43B	-2.09B
Change In Accounts Payable	5.58B	6.02B	-8.03B	-5.53B	-958M
Change in Other Net Operating Assets	1.91B	5.99B	-3.57B	983M	-298M
Cash from Operations	22.06B	24.06B	1B	4.89B	28.82B
Capital Expenditure	-5.86B	-9.37B	-8.05B	-9.84B	-9.57B
Sale of Property, Plant, and Equipment	67M	9M	161M	112M	12.02B
Cash Acquisitions	-	-	-	-	-
Divestitures	-	380M	91M	-	-
Sale (Purchase) of Intangible assets	-188M	-360M	-1.01B	-1.01B	-660M
Investment in Marketable and Equity Securities, Total	816M	102M	94M	-107M	656M
Net (Increase) Decrease in Loans Originated / Sold - Investing	2M	97M	-1M	-	-
Other Investing Activities, Total	-24M	103M	298M	284M	102M
Cash from Investing	-5.19B	-9.04B	-8.42B	-10.56B	2.54B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	10B	15B	-
Total Debt Issued	-	-	10B	15B	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-2B	-2B	-2B	-4B	-5B
Total Debt Repaid	-2B	-2B	-2B	-4B	-5B
Issuance of Common Stock	188M	240M	106M	529M	1.5B
Repurchase of Common Stock	-3B	-2.5B	-1.58B	-922M	-1.38B
Common Dividends Paid	-3.33B	-5.96B	-8.54B	-8.68B	-8.8B
Common & Preferred Stock Dividends Paid	-3.33B	-5.96B	-8.54B	-8.68B	-8.8B
Other Financing Activities, Total	-135M	-133M	-157M	-313M	-317M
Cash from Financing	-8.28B	-10.35B	-2.17B	1.62B	-13.99B
Foreign Exchange Rate Adjustments	429M	706M	625M	755M	404M
Miscellaneous Cash Flow Adjustments	-	-	-	1M	1M
Net Change in Cash	9.02B	5.38B	-8.97B	-3.3B	17.78B
Supplemental Items
Cash Interest Paid	69M	47M	37M	81M	192M
Cash Income Tax Paid (Refund)	1.3B	7.65B	7.64B	10.92B	5.94B
Levered Free Cash Flow	12.65B	11.14B	-9.65B	-9.42B	16.44B
Unlevered Free Cash Flow	12.7B	11.17B	-9.63B	-9.36B	16.57B
Change In Net Working Capital	-5.55B	548M	26B	19.05B	-3.08B
Net Debt Issued / Repaid	-2B	-2B	8B	11B	-5B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.27	10.15	10.8	7.28	8.01
Return on Total Capital	7.93	13.68	14.53	9.2	9.77
Return On Equity %	10.75	17.35	17.11	12.78	15.38
Return on Common Equity	10.8	17.38	17.14	12.79	15.41
Margin Analysis
Gross Profit Margin %	38.02	40.15	42.12	40.66	41.49
SG&A Margin	14.58	12.62	12.79	15.19	14.86
EBITDA Margin %	19.56	24.13	26.14	22.3	23.16
EBITA Margin %	15.94	21.44	23.53	18.83	19.76
EBIT Margin %	15.91	21.42	23.5	18.79	19.73
Income From Continuing Operations Margin %	12.53	16.13	16.14	14.45	17.1
Net Income Margin %	12.54	16.09	16.1	14.39	17.03
Net Avail. For Common Margin %	12.54	16.09	16.1	14.39	17.03
Normalized Net Income Margin	10.22	13.74	14.98	12.24	12.36
Levered Free Cash Flow Margin	13.03	8.36	-6.58	-7	10.92
Unlevered Free Cash Flow Margin	13.08	8.38	-6.56	-6.95	11
Asset Turnover
Asset Turnover	0.63	0.76	0.74	0.62	0.65
Fixed Assets Turnover	2.73	3.33	3.18	2.57	2.74
Receivables Turnover (Average Receivables)	3.21	3.85	3.59	3.13	3.65
Inventory Turnover (Average Inventory)	1.91	2.18	1.81	1.32	1.29
Short Term Liquidity
Current Ratio	2.84	2.4	2.83	3.34	3.61
Quick Ratio	1.9	1.57	1.64	1.73	2.01
Operating Cash Flow to Current Liabilities	0.56	0.43	0.02	0.11	0.61
Days Sales Outstanding (Average Receivables)	113.67	94.79	101.53	117.01	100.06
Days Outstanding Inventory (Average Inventory)	191.13	167.39	201.39	276.4	283.31
Average Days Payable Outstanding	115.89	110.83	97.11	78.55	69.69
Cash Conversion Cycle (Average Days)	188.92	151.34	205.82	314.85	313.67
Long Term Solvency
Total Debt/Equity	6.49	4.19	9.72	15.89	11.4
Total Debt / Total Capital	6.1	4.02	8.86	13.71	10.23
LT Debt/Equity	3.57	1.59	5.9	11.77	7.64
Long-Term Debt / Total Capital	3.35	1.52	5.38	10.15	6.85
Total Liabilities / Total Assets	27.72	31.13	30.14	29.75	25.94
EBIT / Interest Expense	214.61	571.02	862.38	241.04	147.04
EBITDA / Interest Expense	263.83	643.1	959.22	286.06	172.56
(EBITDA - Capex) / Interest Expense	182.39	455.76	757.88	192.3	125.16
Total Debt / EBITDA	0.4	0.17	0.37	0.84	0.58
Net Debt / EBITDA	-1.9	-1.35	-0.67	-0.39	-0.99
Total Debt / (EBITDA - Capex)	0.58	0.24	0.47	1.25	0.79
Net Debt / (EBITDA - Capex)	-2.75	-1.91	-0.85	-0.58	-1.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.44	37.25	10.15	-8.26	11.77
Gross Profit, 1 Yr. Growth %	7.08	44.94	15.57	-11.44	14.04
EBITDA, 1 Yr. Growth %	20.43	69.27	19.33	-21.72	16.05
EBITA, 1 Yr. Growth %	25.61	84.63	20.84	-26.56	17.3
EBIT, 1 Yr. Growth %	25.8	84.77	20.82	-26.63	17.36
Earnings From Cont. Operations, 1 Yr. Growth %	71.23	76.66	10.21	-17.85	32.27
Net Income, 1 Yr. Growth %	70.14	76.11	10.21	-17.99	32.3
Normalized Net Income, 1 Yr. Growth %	27.5	84.53	20.13	-25.06	12.87
Diluted EPS Before Extra, 1 Yr. Growth %	70.71	78.53	10.63	-17.41	32.16
Accounts Receivable, 1 Yr. Growth %	4.42	24.05	13.1	-1.34	-7.02
Inventory, 1 Yr. Growth %	9.07	22.49	32.77	25.7	3.4
Net Property, Plant and Equip., 1 Yr. Growth %	5.94	18.64	12.6	14.39	-3.61
Total Assets, 1 Yr. Growth %	10.24	17.72	9.91	7.89	5.51
Tangible Book Value, 1 Yr. Growth %	7.35	12.89	11.57	8.6	11.64
Common Equity, 1 Yr. Growth %	6.54	12.17	11.46	8.45	11.12
Cash From Operations, 1 Yr. Growth %	269.86	9.07	-95.84	389.2	489.21
Capital Expenditures, 1 Yr. Growth %	32.28	59.74	-14.02	22.24	-2.75
Levered Free Cash Flow, 1 Yr. Growth %	-4.03K	-11.93	-186.64	-2.37	-274.43
Unlevered Free Cash Flow, 1 Yr. Growth %	-4.78K	-12	-186.17	-2.8	-277
Dividend Per Share, 1 Yr. Growth %	10.53	120.24	27.03	-18.3	31.77
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.2	23.12	22.95	0.52	1.26
Gross Profit, 2 Yr. CAGR %	-5.22	24.58	29.42	1.17	0.5
EBITDA, 2 Yr. CAGR %	-9.32	42.78	42.12	-3.35	-4.69
EBITA, 2 Yr. CAGR %	-12.99	52.29	49.37	-5.8	-7.19
EBIT, 2 Yr. CAGR %	-12.58	52.46	49.41	-5.85	-7.21
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.09	73.92	39.53	-4.85	4.24
Net Income, 2 Yr. CAGR %	-8.88	73.1	39.31	-4.93	4.16
Normalized Net Income, 2 Yr. CAGR %	-12.55	53.39	48.89	-5.12	-8.03
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.78	74.58	40.54	-4.41	4.48
Accounts Receivable, 2 Yr. CAGR %	-7.45	13.81	18.45	5.63	-4.22
Inventory, 2 Yr. CAGR %	4.71	15.58	27.53	29.18	14.01
Net Property, Plant and Equip., 2 Yr. CAGR %	5.14	12.11	15.58	13.49	5
Total Assets, 2 Yr. CAGR %	1.26	13.92	13.75	8.89	6.69
Tangible Book Value, 2 Yr. CAGR %	4.38	10.09	12.23	10.08	10.11
Common Equity, 2 Yr. CAGR %	4.33	9.32	11.82	9.95	9.78
Cash From Operations, 2 Yr. CAGR %	30.61	100.84	-78.71	-54.91	436.88
Capital Expenditures, 2 Yr. CAGR %	-27.66	45.36	17.19	2.52	9.03
Levered Free Cash Flow, 2 Yr. CAGR %	301.77	488.47	-12.65	-8.03	30.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	309.57	541.96	-12.92	-8.48	31.17
Dividend Per Share, 2 Yr. CAGR %	-10.56	56.02	67.26	1.87	3.76
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.26	9.5	18.63	11.52	4.14
Gross Profit, 3 Yr. CAGR %	2.4	9.2	21.5	14.05	5.29
EBITDA, 3 Yr. CAGR %	-1.58	11.65	34.49	16.5	2.73
EBITA, 3 Yr. CAGR %	-3.8	11.81	40.99	17.89	1.35
EBIT, 3 Yr. CAGR %	-3.67	12.19	41.09	17.88	1.33
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.61	13.45	49.38	16.94	6.19
Net Income, 3 Yr. CAGR %	-1.44	13.5	48.91	16.76	6.14
Normalized Net Income, 3 Yr. CAGR %	-2.72	12.17	41.39	18.44	0.53
Diluted EPS Before Extra, 3 Yr. CAGR %	-1.4	14.1	49.95	17.72	6.49
Accounts Receivable, 3 Yr. CAGR %	-2.46	2.04	13.57	11.45	1.23
Inventory, 3 Yr. CAGR %	13.78	10.33	21.05	26.91	19.95
Net Property, Plant and Equip., 3 Yr. CAGR %	14.74	9.46	12.28	15.18	7.48
Total Assets, 3 Yr. CAGR %	6.7	6.47	12.57	11.76	7.75
Tangible Book Value, 3 Yr. CAGR %	4.95	7.14	10.58	11.01	10.59
Common Equity, 3 Yr. CAGR %	5.51	6.88	10.03	10.68	10.34
Cash From Operations, 3 Yr. CAGR %	26.38	23	-44.86	-39.47	6.2
Capital Expenditures, 3 Yr. CAGR %	51.72	-5.8	22.02	18.85	0.73
Levered Free Cash Flow, 3 Yr. CAGR %	23.82	142.25	210.74	-9.35	13.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.87	145.31	228.7	-9.67	14.03
Dividend Per Share, 3 Yr. CAGR %	-2.99	20.78	45.69	31.73	11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.68	11.37	10.73	5.82	11.35
Gross Profit, 5 Yr. CAGR %	5.62	12.54	12.46	5.91	12.62
EBITDA, 5 Yr. CAGR %	4.16	14.78	14	5.39	17.18
EBITA, 5 Yr. CAGR %	2.8	15.74	14.71	4.4	19.28
EBIT, 5 Yr. CAGR %	3.17	15.89	14.82	4.59	19.32
Earnings From Cont. Operations, 5 Yr. CAGR %	4.52	16.66	13.15	5.74	29.36
Net Income, 5 Yr. CAGR %	4.64	16.69	13.19	5.73	29.07
Normalized Net Income, 5 Yr. CAGR %	3.84	16.25	15.34	4.91	19.04
Diluted EPS Before Extra, 5 Yr. CAGR %	4.55	16.95	13.62	6.3	29.77
Accounts Receivable, 5 Yr. CAGR %	3.57	6.3	5.42	3.46	6.09
Inventory, 5 Yr. CAGR %	15.38	18.4	19.09	17.52	18.18
Net Property, Plant and Equip., 5 Yr. CAGR %	10.74	12.2	15.08	11.06	9.31
Total Assets, 5 Yr. CAGR %	9.65	10.69	9.46	7.43	10.18
Tangible Book Value, 5 Yr. CAGR %	7.47	8.08	7.8	8.31	10.39
Common Equity, 5 Yr. CAGR %	7.98	8.46	7.99	8.1	9.93
Cash From Operations, 5 Yr. CAGR %	25.07	13.44	-38.02	-17.67	37.03
Capital Expenditures, 5 Yr. CAGR %	13.15	12.85	36.83	-2.55	16.65
Levered Free Cash Flow, 5 Yr. CAGR %	35.72	8.01	7.69	64.44	119.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	35.63	8.03	7.59	65.36	127.62
Dividend Per Share, 5 Yr. CAGR %	7.32	20.77	20.63	12.83	27.19